MedTrace Logo

Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorder

NCT02043197 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2018-12-17

Study results available
· View outcomes & findings →

Summary

Prospective, multicenter, non-comparative, observational program to describe prevalence of depressive symptoms in a variety of neurological disorders and effects of Fevarin® on the severity of anxiety and depression, sleep state, and cognitive function.

Conditions

Sponsors & Collaborators

  • Manipal Acunova Ltd.

    collaborator NETWORK

  • Abbott

    lead INDUSTRY

Principal Investigators

  • Tatiana Vladimirova, MD, PhD · Abbott

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02043197 on ClinicalTrials.gov